Jeffrey Harris
Family Medicine · Greenville, SCNPI 1215134978
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,223 of the $4,224 with a category attached, or 76.3%. 21 manufacturers reported payments, led by Indivior Inc. at 28.2% of the total. Reporting peaked in 2019 at $1,575 and has fallen 79.2% since, to $327 in 2025.
Across 184 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$1K
- Supernus Pharmaceuticals, Inc.$780
- Tris Pharma Inc$467
- Ironshore Pharmaceuticals Inc.$467
- Corium, LLC$307
- Neos Therapeutics, LP$237
- plus $774 from 15 others
Across 169 payments — averaging $20,668 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$757K
- Quidel Corporation$528K
- Covis Pharma GmbH$465K
- Gen-probe, Inc.$457K
- BD$405K
- Orasure Technologies Inc.$232K
- plus $648K from 7 others
What the payments were for
- Speaking & faculty fees$1,00024%
- Food & beverage$3,22376%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 11 | $1,191 |
| Supernus Pharmaceuticals, Inc. | 56 | $780 |
| Tris Pharma Inc | 29 | $467 |
| Ironshore Pharmaceuticals Inc. | 27 | $467 |
| Corium, LLC | 16 | $307 |
| Neos Therapeutics, LP | 12 | $237 |
| Abbott | 1 | $180 |
| AbbVie | 6 | $130 |
| Noven Therapeutics, LLC | 4 | $90 |
| Adlon Therapeutics L.p. | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| AstraZeneca | 3 | $51 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Genentech USA, Inc. | 1 | $22 |
| Rhodes Pharmaceuticals L.p. | 1 | $21 |
| Braeburn Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Pfizer | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$1,000
- Proclaim Family of SCS IPGs$180
How this compares
$4,224 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $2,039 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Greenville
- Steve HamberisGreenville$19K
- Richard LelandGreenville$19K
- Saria SaccocioGreenville$17K
- Eric FaileGreenville$15K
- Naveen BethiGreenville$14K
- James BridgemanGreenville$13K
- Angela SellGreenville$13K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.